In the United States,<unk>  is indicated for active immunization to prevent<unk><unk><unk>  (TBE) in individuals one year of age and older. The efficacy of these vaccines has been well documented. They have also been shown to protect mice from a lethal challenge with several TBE-virus isolates obtained over a period of more than 30 years from all over Europe and the Asian part of the former Soviet Union. In addition, it has been demonstrated that antibodies induced by vaccination of human volunteers neutralized all tested isolates. Pregnancy and breastfeeding The vaccine appears to be safe during pregnancy, but because of insufficient data the vaccine is only recommended during pregnancy and breastfeeding when it is considered urgent to achieve protection against TBE infection and after careful consideration of risks versus benefits. Schedule Two to three doses are recommended depending on the formulation. Typically one to three months should occur between the first doses followed by five to twelve months before the final dose. Additional doses are then recommended every three to five years.
Tick-borne encephalitis vaccine
Japanese encephalitis vaccine
Zika virus vaccine
Dengue vaccine
Malaria vaccine
Rabies vaccine
Hantavirus vaccine
Schistosomiasis vaccine